The clinical relevance of formal thought disorder in the early stages of psychosis: results from the PRONIA study.


Journal

European archives of psychiatry and clinical neuroscience
ISSN: 1433-8491
Titre abrégé: Eur Arch Psychiatry Clin Neurosci
Pays: Germany
ID NLM: 9103030

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 01 05 2021
accepted: 27 08 2021
pubmed: 19 9 2021
medline: 7 4 2022
entrez: 18 9 2021
Statut: ppublish

Résumé

Formal thought disorder (FTD) has been associated with more severe illness courses and functional deficits in patients with psychotic disorders. However, it remains unclear whether the presence of FTD characterises a specific subgroup of patients showing more prominent illness severity, neurocognitive and functional impairments. This study aimed to identify stable and generalizable FTD-subgroups of patients with recent-onset psychosis (ROP) by applying a comprehensive data-driven clustering approach and to test the validity of these subgroups by assessing associations between this FTD-related stratification, social and occupational functioning, and neurocognition. 279 patients with ROP were recruited as part of the multi-site European PRONIA study (Personalised Prognostic Tools for Early Psychosis Management; www.pronia.eu). Five FTD-related symptoms (conceptual disorganization, poverty of content of speech, difficulty in abstract thinking, increased latency of response and poverty of speech) were assessed with Positive and Negative Symptom Scale (PANSS) and the Scale for the Assessment of Negative Symptoms (SANS). The results with two patient subgroups showing different levels of FTD were the most stable and generalizable clustering solution (predicted clustering strength value = 0.86). FTD-High subgroup had lower scores in social (p Clustering techniques allowed us to identify patients with more pronounced FTD showing more severe deficits in functioning and neurocognition, thus suggesting that FTD may be a relevant marker of illness severity in the early psychosis pathway.

Sections du résumé

BACKGROUND BACKGROUND
Formal thought disorder (FTD) has been associated with more severe illness courses and functional deficits in patients with psychotic disorders. However, it remains unclear whether the presence of FTD characterises a specific subgroup of patients showing more prominent illness severity, neurocognitive and functional impairments. This study aimed to identify stable and generalizable FTD-subgroups of patients with recent-onset psychosis (ROP) by applying a comprehensive data-driven clustering approach and to test the validity of these subgroups by assessing associations between this FTD-related stratification, social and occupational functioning, and neurocognition.
METHODS METHODS
279 patients with ROP were recruited as part of the multi-site European PRONIA study (Personalised Prognostic Tools for Early Psychosis Management; www.pronia.eu). Five FTD-related symptoms (conceptual disorganization, poverty of content of speech, difficulty in abstract thinking, increased latency of response and poverty of speech) were assessed with Positive and Negative Symptom Scale (PANSS) and the Scale for the Assessment of Negative Symptoms (SANS).
RESULTS RESULTS
The results with two patient subgroups showing different levels of FTD were the most stable and generalizable clustering solution (predicted clustering strength value = 0.86). FTD-High subgroup had lower scores in social (p
CONCLUSIONS CONCLUSIONS
Clustering techniques allowed us to identify patients with more pronounced FTD showing more severe deficits in functioning and neurocognition, thus suggesting that FTD may be a relevant marker of illness severity in the early psychosis pathway.

Identifiants

pubmed: 34535813
doi: 10.1007/s00406-021-01327-y
pii: 10.1007/s00406-021-01327-y
pmc: PMC8938366
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

403-413

Subventions

Organisme : the Structural European Funding of the Italian Minister of Education (Attraction and International Mobility - AIM - action
ID : 1859959

Informations de copyright

© 2021. The Author(s).

Références

Schizophr Bull. 2007 May;33(3):688-702
pubmed: 17440198
Schizophr Bull. 1986;12(3):348-59
pubmed: 3764356
Schizophr Res. 2016 Dec;178(1-3):29-34
pubmed: 27639419
Eur Psychiatry. 2015 Mar;30(3):405-16
pubmed: 25735810
Br J Psychiatry. 1993 Jan;162:80-6
pubmed: 8425144
Schizophr Res. 2010 Aug;121(1-3):1-14
pubmed: 20579855
Eur Arch Psychiatry Clin Neurosci. 2022 Apr;272(3):381-393
pubmed: 34263359
Annu Rev Clin Psychol. 2018 May 7;14:91-118
pubmed: 29401044
Psychol Med. 2016 Sep;46(12):2455-65
pubmed: 27406289
Schizophr Res. 2014 Dec;160(1-3):216-21
pubmed: 25458572
Lancet Psychiatry. 2018 Jun;5(6):515-526
pubmed: 29678679
Schizophr Res. 2014 Jan;152(1):242-5
pubmed: 24291545
Schizophr Bull. 2017 Jan 15;43(3):514-522
pubmed: 28204762
Schizophr Bull. 2015 Jul;41(4):951-62
pubmed: 25180313
IEEE Trans Pattern Anal Mach Intell. 1979 Feb;1(2):224-7
pubmed: 21868852
JAMA Psychiatry. 2013 Nov;70(11):1133-42
pubmed: 24006090
Schizophr Bull. 1986;12(3):373-93
pubmed: 3764358
Neuropsychobiology. 2012 Jun;65(4):206-15
pubmed: 22653086
Eur Arch Psychiatry Clin Neurosci. 2018 Feb;268(1):39-48
pubmed: 28054132
J Psychiatr Res. 2017 Oct;93:37-49
pubmed: 28578207
Compr Psychiatry. 2012 Aug;53(6):674-8
pubmed: 22341649
Schizophr Res. 2014 Mar;153(1-3):196-203
pubmed: 24485197
Dialogues Clin Neurosci. 2015 Mar;17(1):9-18
pubmed: 25987859
Arch Gen Psychiatry. 1996 Apr;53(4):358-64
pubmed: 8634014
Br J Psychiatry Suppl. 1989 Nov;(7):49-58
pubmed: 2695141
Compr Psychiatry. 2016 Oct;70:98-104
pubmed: 27624428
World Psychiatry. 2017 Feb;16(1):14-24
pubmed: 28127915
Front Psychiatry. 2018 Nov 09;9:572
pubmed: 30473667
Neuropsychobiology. 2016;73(3):139-47
pubmed: 27058747
Biochem Med (Zagreb). 2013;23(2):143-9
pubmed: 23894860
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Biometrika. 1947;34(1-2):28-35
pubmed: 20287819
Schizophr Bull. 1986;12(3):473-82
pubmed: 3764363
Neuro Endocrinol Lett. 2012;33(3):347-55
pubmed: 22635096
Arch Gen Psychiatry. 1987 Jul;44(7):651-9
pubmed: 3606331
Early Interv Psychiatry. 2017 Feb;11(1):23-36
pubmed: 25585960
J Nerv Ment Dis. 1999 May;187(5):281-9
pubmed: 10348082
Science. 2015 May 1;348(6234):499-500
pubmed: 25931539
J Am Acad Child Adolesc Psychiatry. 2011 Jul;50(7):669-80
pubmed: 21703494
Schizophr Res. 2016 Jul;174(1-3):71-76
pubmed: 27197904
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Mar;3(3):223-230
pubmed: 29486863
Schizophr Bull. 2012 Mar;38(2):263-71
pubmed: 20554785
Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Sep;1(5):433-447
pubmed: 27642641
JAMA Psychiatry. 2018 Nov 1;75(11):1156-1172
pubmed: 30267047
Schizophr Res Treatment. 2012;2012:916198
pubmed: 22966451
Br J Psychiatry. 2002 Oct;181:326-30
pubmed: 12356660

Auteurs

Oemer Faruk Oeztuerk (OF)

Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University Munich, Nussbaumstr. 7, 80336, Munich, Germany. oemer.oeztuerk@med.uni-muenchen.de.
International Max Planck Research School for Translational Psychiatry, Munich, Germany. oemer.oeztuerk@med.uni-muenchen.de.
Max Planck Institute for Psychiatry, Munich, Germany. oemer.oeztuerk@med.uni-muenchen.de.

Alessandro Pigoni (A)

MoMiLab Research Unit, IMT School for Advanced Studies Lucca, Lucca, Italy.

Julian Wenzel (J)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.

Shalaila S Haas (SS)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA.

David Popovic (D)

Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University Munich, Nussbaumstr. 7, 80336, Munich, Germany.
International Max Planck Research School for Translational Psychiatry, Munich, Germany.

Anne Ruef (A)

Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University Munich, Nussbaumstr. 7, 80336, Munich, Germany.

Dominic B Dwyer (DB)

Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University Munich, Nussbaumstr. 7, 80336, Munich, Germany.

Lana Kambeitz-Ilankovic (L)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.

Stephan Ruhrmann (S)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.

Katharine Chisholm (K)

School of Psychology, Aston University, Birmingham, UK.

Paris Lalousis (P)

Institute for Mental Health, University of Birmingham, Birmingham, UK.

Sian Lowri Griffiths (SL)

Institute for Mental Health, University of Birmingham, Birmingham, UK.

Theresa Lichtenstein (T)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.

Marlene Rosen (M)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.

Joseph Kambeitz (J)

Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.

Frauke Schultze-Lutter (F)

Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.

Peter Liddle (P)

Division of Psychiatry and Applied Psychology, Institute of Mental Health, University of Nottingham, Nottingham, UK.

Rachel Upthegrove (R)

School of Psychology, Aston University, Birmingham, UK.
Institute for Mental Health, University of Birmingham, Birmingham, UK.

Raimo K R Salokangas (RKR)

Department of Psychiatry, University of Turku, Turku, Finland.

Christos Pantelis (C)

Melbourne Neuropsychiatry Centre, University of Melbourne, Melbourne, Australia.
Melbourne Health, Melbourne, Australia.

Eva Meisenzahl (E)

Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.

Stephen J Wood (SJ)

School of Psychology, University of Birmingham, Birmingham, UK.
Orygen, The National Centre of Excellence for Youth Mental Health, Melbourne, Australia.
Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Paolo Brambilla (P)

Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.

Stefan Borgwardt (S)

Department of Psychiatry, University Psychiatric Clinic, Psychiatric University Hospital, University of Basel, Basel, Switzerland.

Peter Falkai (P)

Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University Munich, Nussbaumstr. 7, 80336, Munich, Germany.

Linda A Antonucci (LA)

Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University Munich, Nussbaumstr. 7, 80336, Munich, Germany.
Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari "Aldo Moro", Bari, Italy.
Department of Education, Psychology and Communication Science, University of Bari "Aldo Moro", Bari, Italy.

Nikolaos Koutsouleris (N)

Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University Munich, Nussbaumstr. 7, 80336, Munich, Germany.
Max Planck Institute for Psychiatry, Munich, Germany.
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH